Wordt geladen...
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
BACKGROUND: We have harnessed a novel biological system, the bacterial minicell, to deliver cancer therapeutics to cancer cells. Preclinical studies showed that epidermal growth factor receptor (EGFR)-targeted, paclitaxel-loaded minicells ((EGFR)minicells(Pac)) have antitumor effects in xenograft mo...
Bewaard in:
Gepubliceerd in: | PLoS One |
---|---|
Hoofdauteurs: | , , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Public Library of Science
2015
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4699457/ https://ncbi.nlm.nih.gov/pubmed/26659127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144559 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|